Navigation Links
Failure to Take Medicine Linked to Unnecessary Hospital Visits, Especially for Medicare Patients Taking High Blood Pressure or High Cholesterol Medications
Date:5/11/2012

overall than the broader population," said Dr. Woody Eisenberg, chief medical officer for Medicare and a co-author of the research.  "Still, the issue of nonadherence is significant and is one that can be addressed by health care policy makers that are trying to manage Medicare costs by including pharmacists as providers of clinical care with a focus on adherence to essential medications."  

Express Scripts has recently launched ScreenRx(SM), a breakthrough solution in the fight against the nation's costliest health condition: medication nonadherence.

ScreenRx is a proprietary adherence solution from the Express Scripts Research & News Solutions Lab. It detects future risk for nonadherence and tailors interventions for individual patients. Leveraging the power of predictive modeling, the tool identifies patients at highest risk for not following their doctors' orders. Once identified, patients receive personalized interventions to help them stay on their therapy.

In 2011, medication nonadherence cost the United States healthcare system $317.4 billion in treating medical complications that could have been avoided if patients had taken their medication.  This amount is higher than the total medical cost of treating diabetes, congestive heart failure and cancer combined.

Details of Studies

Combined, both studies examined the pharmacy and medical claims of more than 500,000 Americans aged 65 and older using cardiovascular medications from January 2009 through June 2011.  The level of medication adherence was determined by the Proportion of Days Covered (PDC) over one year, meaning the percent of days that patients had medication on hand during that time-frame. Those with a PDC of 80 percent or higher were regarded as adherent, fol
'/>"/>

SOURCE Express Scripts
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. American Oriental Bioengineering Inc. Receives NYSE Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
2. Celladon Corporation Completes $43 Million Financing to Advance MYDICAR® for the Treatment of Heart Failure
3. FDA Approves Mechanical Cardiac Assist Device for Children With Heart Failure
4. Celladon Corporation Receives FDA Fast Track Designation for Its Investigational Agent MYDICAR® for the Treatment of Heart Failure
5. FDA Advisory Panel Recommends Against Approval of Champion® Heart Failure Management System for Patients With Heart Failure
6. Heart Hospital of Austin Physician First in Texas to Implant New Heart Failure Device
7. Drugs for Treating Congestive Heart Failure: Global Markets
8. Hypertronics Partners with UBM Canon, the Leading Global Medical Device Industry Source, to Co-Host Strategies for Avoiding Device Failure Seminar
9. Nile Therapeutics Completes Dosing of Clinical Trial Evaluating the Subcutaneous Infusion of Cenderitide in Chronic Heart Failure Patients
10. American Oriental Bioengineering Inc. Receives NYSE Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
11. Study Uncovers Key Success Factors and Common Failure Points for Launching New Metabolic Products in Todays Competitive Healthcare Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... 1, 2015 CytRx Corporation (NASDAQ: ... specializing in oncology, today announced that Steven ... and David Haen , Vice President of ... corporate overview at two significant investment conferences in ... industries: the FBR & Co. Second Annual Health ...
(Date:9/1/2015)... 1, 2015 Pressure BioSciences, Inc. (OTCQB: ... the development and sale of broadly enabling, pressure ... worldwide life sciences industry, today announced the publication ... Company,s PCT Platform could play a significant role ... role is based on PCT,s unique ability to ...
(Date:9/1/2015)... , September 1, 2015 ... company, today announces that it has appointed Hilde ... Non-Executive Directors to its Board of Directors, effective immediately. ... years of experience in pharma and biotech and is ... a Sanofi company. Previously her role was Vice President ...
Breaking Medicine Technology:CytRx Announces Participation at FBR & Co. Second Annual Health Conference and Rodman & Renshaw 17th Annual Global Investment Conference 2CytRx Announces Participation at FBR & Co. Second Annual Health Conference and Rodman & Renshaw 17th Annual Global Investment Conference 3CytRx Announces Participation at FBR & Co. Second Annual Health Conference and Rodman & Renshaw 17th Annual Global Investment Conference 4New Scientific Publication Suggests Pressure BioSciences' PCT Platform Could Play Significant Role in Personalized/Precision Medicine 2New Scientific Publication Suggests Pressure BioSciences' PCT Platform Could Play Significant Role in Personalized/Precision Medicine 3New Scientific Publication Suggests Pressure BioSciences' PCT Platform Could Play Significant Role in Personalized/Precision Medicine 4New Scientific Publication Suggests Pressure BioSciences' PCT Platform Could Play Significant Role in Personalized/Precision Medicine 5BerGenBio Appoints Non-Executive Directors 2
... Pricing of $500 Million of Senior Notes in Connection with... -- ARDEE, Ireland, Sept. 24 ... ... lpUnit=,PRN,; --> ... { var s = ,; var first_result; // Results are keyed by longUrl, so we need to ...
... Misonix, Inc. (Nasdaq: MSON ), a ... technology, which worldwide is used for acute health conditions, ... ended June 30, 2010 financial results on Tuesday, September ... Officer and Richard Zaremba, Senior VP and Chief Financial ...
Cached Medicine Technology:Warner Chilcott Announces Pricing of $500 Million of Senior Notes in Connection with Agreement to Acquire U.S. Rights to Enablex® 2Warner Chilcott Announces Pricing of $500 Million of Senior Notes in Connection with Agreement to Acquire U.S. Rights to Enablex® 3Warner Chilcott Announces Pricing of $500 Million of Senior Notes in Connection with Agreement to Acquire U.S. Rights to Enablex® 4Warner Chilcott Announces Pricing of $500 Million of Senior Notes in Connection with Agreement to Acquire U.S. Rights to Enablex® 5Warner Chilcott Announces Pricing of $500 Million of Senior Notes in Connection with Agreement to Acquire U.S. Rights to Enablex® 6Warner Chilcott Announces Pricing of $500 Million of Senior Notes in Connection with Agreement to Acquire U.S. Rights to Enablex® 7Warner Chilcott Announces Pricing of $500 Million of Senior Notes in Connection with Agreement to Acquire U.S. Rights to Enablex® 8Misonix Schedules Fourth Quarter and Fiscal 2010 Financial Results Conference Call; September 28, 2010 at 4:30 p.m. Eastern 2
(Date:9/1/2015)... ... September 01, 2015 , ... PetPace, the provider of an ... and activity, today announced its integration with leading veterinary Practice Management Software vendor ... hospital Practice Management Software packages in the US. Practice Management Software helps veterinarians ...
(Date:9/1/2015)... New York, New York (PRWEB) , ... September 01, 2015 , ... ... of Zecurion Zlock Mac , its groundbreaking new version of endpoint DLP developed ... testing of Zlock Mac, in which more than 100 IT and information security professionals ...
(Date:9/1/2015)... ... September 01, 2015 , ... SC&H Group, a leading audit, tax, and consulting ... “Best of the Best” firm in the U.S., as well as being ranked a ... Best” in the U.S., selected exclusively on performance in specific areas of financial and ...
(Date:9/1/2015)... ... September 01, 2015 , ... CanAm Enterprises LLC, (“CanAm”) is ... green cards (I-829 petition approval) from the USCIS through an investment in one ... of the EB-5 visa process for immigrant investors to become lawful permanent residents ...
(Date:9/1/2015)... ... September 01, 2015 , ... ... collection of products, the VitaSkin™ Exfoliating Peels. This revolutionary collection of natural peel ... Bright, Calm, and Clear. , Formulated with alpha hydroxy acids and natural ...
Breaking Medicine News(10 mins):Health News:Petpace-Cornerstone Integration Lowers Overhead, Raises Data Visibility for Veterinary Practices 2Health News:Zecurion Announces Endpoint Security for Mac 2Health News:SC&H Group Receives Multiple Honors from INSIDE Public Accounting 2Health News:CanAm Enterprises Reaches Another Milestone with More Than 1,500 I-829 Petition Approvals 2Health News:Éminence Organic Skin Care Introduces Results-Oriented Exfoliating Peels for Every Skin Type 2Health News:Éminence Organic Skin Care Introduces Results-Oriented Exfoliating Peels for Every Skin Type 3
... breast cancer on screening mammography report no family history, a new ... Care, LLC in Rochester, NY of all breast cancers diagnosed between ... were found in women, aged 40-49 with no family history of ... a prior personal history of breast cancer or abnormal cells at ...
... By Steven Reinberg HealthDay Reporter , WEDNESDAY, ... a heart valve disease known as aortic stenosis, a ... effective, French researchers say. Transcatheter aortic-valve implantation is ... valve than traditional open-heart surgery. The procedure involves passing ...
... HealthDay Reporter , WEDNESDAY, May 2 (HealthDay News) -- ... (bird) flu virus can morph -- with the possibility that it ... -- may help nations prepare for the impending threat. That,s ... study in the May 2 online issue of Nature , ...
... mTOR stops the growth of primary liver cancer and destroys ... Group of Metabolism and Cancer at Bellvitge Biomedical Research Institute ... edition of the journal Science Translational Medicine . ... common cancer and, due to its aggressiveness, is the third ...
... 2012. Kessler Foundation will be represented by four scientists at ... to be held at the Congress Center in Bordeaux, France ... Foundation,s VP of Research and Training will attend with research ... PhD. Kessler Foundation is known for rehabilitation research ...
... 2 (HealthDay News) -- Chemistry in three areas of ... small study says. Along with providing new information ... important in finding ways to treat depression, schizophrenia, attention-deficit ... decreased motivation, Vanderbilt University researchers said. The researchers ...
Cached Medicine News:Health News:Less Invasive Heart Valve Replacement Works for Elderly: Study 2Health News:Less Invasive Heart Valve Replacement Works for Elderly: Study 3Health News:Once-Banned Bird Flu Study Suggests Pandemic Threat Is Real 2Health News:Once-Banned Bird Flu Study Suggests Pandemic Threat Is Real 3Health News:Combination of 2 drugs reverses liver tumors 2Health News:Clues to 'Slacker' Behavior Found in Brain, Study Says 2
Inquire...
Calss II Type B2 Biological Safety Cabinet...
External Calibration Only. Built-in RS232 Interface, Shimadzu WindowsDirect communication function. 120/240V A/C adapter....
... Semi-Micro balance. Built-in, motor-driven internal ... Performs Fully Automatic Self-Calibration when temperature ... intervals. Menu-selected weighing parameters, plug-in ... function keypads make this balance series ...
Medicine Products: